Highlighting AI’s role in improving colonoscopy detection, emergency care, and personalized medicine, Dr. D. Nageshwar Reddy, ...

The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...

Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...

The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...

Dr. Reddy's Laboratories Ltd. closed 16.44% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Regular screenings are crucial because the gradual effect Glaucoma has on one's vision will often catch patients unaware.

Dr. Reddy's Laboratories is among India’s leading pharmaceutical companies. The company is primarily known for manufacturing active pharmaceutical ingredients (APIs). Dr. Reddy's Laboratories ...

Dr. Reddy's Laboratories Ltd. closed 15.55% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...